RUBBEREX CORPORATION (M) Rubberex Corporation (M) Share Price
Equities
HEXCARE
MYL7803OO009
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.205 MYR | +2.50% |
|
-2.38% | -29.31% |
| 04-08 | Hextar Healthcare Berhad Announces the Resignation of Wong Yee Leng as Company Secretary | CI |
| 04-08 | Hextar Healthcare Berhad Announces the Appointment of Ong Wai Leng as Company Secretary | CI |
| Sales 2021 | 515M 108M 8.64B | Sales 2022 | 179M 37.57M 3.01B | Capitalization | 371M 77.8M 6.23B |
|---|---|---|---|---|---|
| Net income 2021 | 186M 39.03M 3.12B | Net income 2022 | -55M -11.54M -924M | EV / Sales 2021 | 0.31 x |
| Net cash position 2021 | 297M 62.23M 4.98B | Net cash position 2022 | 3.84M 807K 64.55M | EV / Sales 2022 | 2.05 x |
| P/E ratio 2021 |
2.38
x | P/E ratio 2022 |
-5.95
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 41.17% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.50% | ||
| 1 week | -2.38% | ||
| 3 months | -16.33% | ||
| 6 months | +2.50% | ||
| Current year | -29.31% |
1 week
0.20
0.21
1 month
0.200.22
Current year
0.200.31
1 year
0.200.35
3 years
0.201.46
5 years
0.143.05
10 years
0.143.05
| Managers | Title | Age | Since |
|---|---|---|---|
Chin Leng Khoo
CEO | Chief Executive Officer | 65 | 30/06/13 |
Stephanie Hew
IRC | Investor Relations Contact | - | - |
| Corporate Secretary | - | 11-21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yee Fuan Sim
BRD | Director/Board Member | 57 | 25/05/23 |
Chin Leng Khoo
CEO | Chief Executive Officer | 65 | 30/06/13 |
Jee Min Chong
CHM | Chairman | 65 | 11/08/21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 0.205 | +2.50% | 476,500 |
| 25/04/24 | 0.2 | -2.44% | 761,200 |
| 24/04/24 | 0.205 | 0.00% | 286,500 |
| 23/04/24 | 0.205 | 0.00% | 7,500,800 |
| 22/04/24 | 0.205 | -2.38% | 310,600 |
End-of-day quote BURSA MALAYSIA, April 25, 2024
More quotes
Hextar Healthcare Bhd is a Malaysia-based investment holding company. The Company's business comprises the manufacturing and sale of gloves. Its principal activities are manufacturing and sale of in-vitro diagnostic (IVD) medical devices. The Company produces natural rubber and synthetic rubber gloves for healthcare, industrial and professional applications. Its segment includes gloves operation, medical devices operation, and investment holding. The Company offers a range of gloves for industrial use, household use, and disposable. The Company's industrial and household use products include Latex, Neoprene, Nitrile and Two Tone.
Calendar
21/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -29.31% | 43.08M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- HEXCARE Stock
